mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |